Guardant Health, Inc.
GH
$98.14
-$0.78-0.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.18% | -4.98% | 14.28% | -3.02% | -4.99% |
| Total Depreciation and Amortization | -6.31% | -1.90% | -2.09% | -1.36% | -0.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.47% | 9.31% | 19.22% | -34.43% | 12.76% |
| Change in Net Operating Assets | 84.49% | 13.27% | -724.08% | 76.78% | 77.28% |
| Cash from Operations | 41.26% | 3.83% | 2.83% | -26.35% | 45.68% |
| Capital Expenditure | -83.22% | -26.69% | 76.38% | -349.51% | 17.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20.00% | -101.63% | 945.14% | 110.12% | -- |
| Cash from Investing | -34.75% | -103.52% | 2,776.20% | 103.57% | -5,707.11% |
| Total Debt Issued | 200.00% | -200.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -59.72% | 1,102.73% | -84.73% | 25,045.00% | -99.79% |
| Repurchase of Common Stock | 69.48% | 87.74% | -654.17% | -179.16% | 11.30% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -144.54% | 139.85% | -20,677.97% | 290.32% | 92.92% |
| Cash from Financing | 166.69% | 102.43% | -2,177.68% | -1.73% | -148.91% |
| Foreign Exchange rate Adjustments | -156.88% | 21.22% | 145.60% | -189.21% | 327.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.77% | -139.27% | 397.03% | 83.10% | -268.94% |